| 10477 | HSAP00P0000064784 | -1.392 | 10.03 | -8.407 | 3.192e-07 | 0.0005144 | 6.886 | UBE2E3 | ubiquitin-conjugating enzyme E2E 3 | ENSG00000170035 | 604151 | 10477 | NM_006357 |
| 1937 | HSAP00P0000239653 | -0.8571 | 12.52 | -3.971 | 0.001124 | 0.03631 | -0.7935 | EEF1G | eukaryotic translation elongation factor 1 gamma | ENSG00000255508, ENSG00000254772 | 130593 | 1937 | NM_001404 |
| 22911 | HSAP00P0000020922 | 1.011 | 8.063 | 5.956 | 2.128e-05 | 0.004637 | 2.99 | WDR47 | WD repeat domain 47 | ENSG00000085433 | NA | 22911 | NM_014969 |
| 23476 | HSAP00P0000374398 | 0.417 | 6.712 | 2.032 | 0.0593 | 0.2725 | -4.48 | BRD4 | bromodomain containing 4 | ENSG00000141867 | 608749 | 23476 | BC008354 |
| 2550 | HSAP00P0000137229 | 0.893 | 6.085 | 3.356 | 0.004078 | 0.07022 | -2.018 | GABBR1 | gamma-aminobutyric acid (GABA) B receptor, 1 | ENSG00000232569, ENSG00000237051, ENSG00000206466, ENSG00000237112, ENSG00000204681, ENSG00000206511, ENSG00000232632 | 603540 | 2550 | BC041332 |
| 3065 | HSAP00P0000010163 | -0.5626 | 10.6 | -2.45 | 0.02635 | 0.1806 | -3.754 | HDAC1 | histone deacetylase 1 | ENSG00000116478 | 601241 | 3065 | NM_004964 |
| 3682 | HSAP00P0000334454 | -1.036 | 9.113 | -5.698 | 3.471e-05 | 0.006026 | 2.526 | ITGAE | integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) | ENSG00000083457 | 604682 | 3682 | NM_002208 |
| 4085 | HSAP00P0000109089 | -1.773 | 6.94 | -6.174 | 1.416e-05 | 0.003749 | 3.375 | MAD2L1 | MAD2 mitotic arrest deficient-like 1 (yeast) | ENSG00000164109 | 601467 | 4085 | BC000356 |
| 51619 | HSAP00P0000161153 | -0.635 | 8.36 | -3.144 | 0.006352 | 0.08796 | -2.436 | UBE2D4 | ubiquitin-conjugating enzyme E2D 4 (putative) | ENSG00000078967 | NA | 51619 | AF125045 |
| 5347 | HSAP00P0000320604 | -2.8 | 7.923 | -9.265 | 8.79e-08 | 0.0002936 | 8.039 | PLK1 | polo-like kinase 1 | ENSG00000166851 | 602098 | 5347 | NM_005030 |
| 5371 | HSAP00P0000308453 | 0.5752 | 6.425 | 3.063 | 0.007527 | 0.09588 | -2.595 | PML | promyelocytic leukemia | ENSG00000140464 | 102578 | 5371 | NM_033238 |
| 55284 | HSAP00P0000183964 | -0.6786 | 6.252 | -2.561 | 0.02109 | 0.1616 | -3.551 | UBE2W | ubiquitin-conjugating enzyme E2W (putative) | ENSG00000104343 | NA | 55284 | NM_001001481 |
| 55743 | HSAP00P0000277102 | 0.3902 | 7.235 | 2.041 | 0.05838 | 0.2704 | -4.466 | CHFR | checkpoint with forkhead and ring finger domains | ENSG00000072609 | 605209 | 55743 | BC012072 |
| 6790 | HSAP00P0000402773 | -1.977 | 6.923 | -7.989 | 6.18e-07 | 0.0007058 | 6.287 | AURKA | aurora kinase A | ENSG00000087586 | 114500, 603072 | 6790 | NM_198433 |
| 7316 | HSAP00P0000276004 | -0.7127 | 12.93 | -3.906 | 0.001285 | 0.03906 | -0.9215 | UBC | ubiquitin C | ENSG00000150991 | 191340 | 7316 | BC014880 |
| 7321 | HSAP00P0000216076 | 0.8886 | 4.61 | 2.288 | 0.0363 | 0.2123 | -4.044 | UBE2D1 | ubiquitin-conjugating enzyme E2D 1 | ENSG00000072401 | 602961 | 7321 | NM_003338 |
| 7322 | HSAP00P0000125486 | -1.15 | 7.776 | -3.78 | 0.001676 | 0.04478 | -1.175 | UBE2D2 | ubiquitin-conjugating enzyme E2D 2 | ENSG00000131508 | 602962 | 7322 | U39317 |
| 7323 | HSAP00P0000107776 | -1.407 | 8.224 | -5.734 | 3.24e-05 | 0.0058 | 2.592 | UBE2D3 | ubiquitin-conjugating enzyme E2D 3 | ENSG00000109332 | 602963 | 7323 | NM_181893 |
| 7324 | HSAP00P0000075986 | -2.054 | 11.07 | -6.469 | 8.255e-06 | 0.002753 | 3.884 | UBE2E1 | ubiquitin-conjugating enzyme E2E 1 | ENSG00000170142 | 602916 | 7324 | NM_003341 |
| 7325 | HSAP00P0000075965 | -1.281 | 6.939 | -3.829 | 0.001511 | 0.04237 | -1.076 | UBE2E2 | ubiquitin-conjugating enzyme E2E 2 | ENSG00000182247 | 602163 | 7325 | NM_152653 |
| 7334 | HSAP00P0000269516 | -1.758 | 7.27 | -6.171 | 1.426e-05 | 0.003753 | 3.369 | UBE2N | ubiquitin-conjugating enzyme E2N | ENSG00000177889 | 603679 | 7334 | NM_003348 |
| 7874 | HSAP00P0000317584 | -1.571 | 8.246 | -4.839 | 0.0001879 | 0.01468 | 0.916 | USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | ENSG00000187555 | 602519 | 7874 | AY376241 |